Drugs / Autologous Human Placental Cord Blood Mononuclear Cells
Autologous Human Placental Cord Blood Mononuclear Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03431480 | Feb 2018 → Nov 2021 | hypoplastic left heart syndrome | Murdoch Childrens Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Human Placental Cord Blood Mononuclear Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03431480 ↗ |
| Modality | Cell therapy | “autologous cord blood stem cell therapy” PMID 37527726 ↗ Jul 2023 |
| Route | Other | “are infused into the coronary artery during the Norwood heart operation” NCT03431480 ↗ |